17 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34729910 | Investigating interactions between chloroquine/hydroxychloroquine and their single enantiomers and angiotensin-converting enzyme 2 by a cell membrane chromatography method. | 2022 Jan | 5 |
2 | 32362217 | In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. | 2021 Jun | 1 |
3 | 32375574 | Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. | 2021 Jul | 1 |
4 | 32677545 | Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study. | 2021 Sep | 2 |
5 | 32752951 | Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2. | 2021 Nov | 1 |
6 | 33518803 | Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with angiotensin converting enzyme-2 receptor: An insight from molecular docking and MD-simulation studies. | 2021 Apr 15 | 5 |
7 | 33639976 | Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice. | 2021 Feb 27 | 1 |
8 | 33706683 | Potential inhibitors of angiotensin converting enzyme 2 receptor of COVID-19 by Corchorus olitorius Linn using docking, molecular dynamics, conceptual DFT investigation and pharmacophore mapping. | 2021 Mar 11 | 1 |
9 | 33750821 | Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2. | 2021 Mar 9 | 1 |
10 | 33979123 | Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2. | 2021 Jun 11 | 1 |
11 | 34017843 | ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes. | 2021 | 1 |
12 | 34130375 | Blocking the interactions between human ACE2 and coronavirus spike glycoprotein by selected drugs: a computational perspective. | 2021 Jun | 1 |
13 | 32522067 | Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine. | 2020 Dec | 1 |
14 | 32714335 | Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine. | 2020 | 1 |
15 | 32738306 | In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection. | 2020 Sep | 2 |
16 | 32784543 | Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype? | 2020 Aug 7 | 1 |
17 | 32920291 | Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus. | 2020 Dec | 8 |